about
Essential Medicines in a High Income Country: Essential to Whom?Professional Use of Social Media by Pharmacists: A Qualitative StudyThe Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' PerspectivesProvision of opioid substitution therapy services in Australian pharmacies.Incorporating a Weight Management Skills Workshop in Pharmacy Curricula in Australia.Educational interventions to improve prescribing competency: a systematic review.Consumer perspectives about weight management services in a community pharmacy setting in NSW, Australia.Professional ethics in pharmacy practice: developing a psychometric measure of moral reasoning.Medicine shortages: Implications for the Australian healthcare system.Validating a hospital medicines formulary survey in the Western Pacific Region--a global hospital pharmacy initiative based on the Basel Statements.The impact of clinical pharmacy services in China on the quality use of medicines: a systematic review in context of China's current healthcare reform.Clinical pharmacy services that influence prescribing in the Western Pacific Region based on the FIP Basel Statements.Weight management in community pharmacy: what do the experts think?Revision of the International Pharmaceutical Federation's Basel Statements on the future of hospital pharmacy: From Basel to Bangkok.Medicine shortages in Australia: causes, impact and management strategies in the community setting.Perspectives and experiences of patients with type 2 diabetes observing the Ramadan fast.Factors influencing pharmacy services in opioid substitution treatment.Preparing hospital pharmacists to prescribe: stakeholders' views of postgraduate courses.Mifepristone (RU486) in Australian pharmacies: the ethical and practical challenges.Pharmacists' perceptions of professionalism on social networking sites.Fitness to practise in pharmacy: a study of impairment in professional practice.Senior nurses' perspectives on the transfer of opioid substitution treatment clients from clinics to community pharmacy.Emergency contraception in Australian community pharmacies: a simulated patient study.Medicines and disease information needs of older Arabic-speaking Australians.Identifying perceptions of academic reform in pharmacy using a four-frame organizational change model.Developing and testing evidence-based weight management in Australian pharmacies: A Healthier Life Program.Factors affecting the implementation of clinical pharmacy services in China.Asthma management experiences of Australians who are native Arabic speakers.Medicine procurement in hospital pharmacies of Nepal: A qualitative study based on the Basel Statements.Pharmacists' influences on prescribing: validating a clinical pharmacy services survey in the Western Pacific Region.World Hospital Pharmacy Research ConsortiumHospital pharmacy services in the Pacific Island countriesFormulary systems and pharmacy and therapeutics committees in the Western Pacific Region: Exploring two Basel StatementsInvestment Opportunities in Australia’s Healthcare Stock Markets After the Recent Global Financial CrisisPredicting ASX Health Care Stock Index Movements After the Recent Financial Crisis Using Patterned Neural NetworksStakeholders' Perspectives on Quality Assurance of Pharmacy Education in the Eastern Mediterranean RegionCompetency-based pharmacy education in the Eastern Mediterranean Region—A scoping reviewGeneral Practitioners' experiences of asthma management in culturally and linguistically diverse populationsStakeholder roles in facilitating access to essential medicinesDiffering clinical pharmacy service models: Quantitative and qualitative analysis of nurse perceptions of support from pharmacists
P50
Q28551437-7F3CF0F8-DED0-44CB-80FB-1884A745CA31Q28597818-844103CF-9304-447F-9297-3D7511D3CA30Q36015888-E21F1284-B0F2-40E7-8605-BC480075AF2AQ36583499-157154B8-FB56-4BD7-9B8C-3CEEAC3FFDB6Q36965559-A1A60922-988B-4A4C-A2C4-6F73636858ABQ37136854-DBF89951-BCBB-4DA6-8743-FFD980DEBAB5Q37333154-A30122C7-F344-42D1-8417-07C24C687AA1Q37421525-0649B324-D1EA-484C-8704-0D72DBD9E0ABQ37681429-84EFA12A-5F34-4303-9DCC-B2C96299B05AQ37968394-D2AC5799-3C8C-4BE7-ADBA-53B6ED9B78BAQ38140645-F2AE43A2-7351-4033-A0A7-EC269745A21CQ38366992-FB41463A-4B81-45D0-9385-8E876A2B02A2Q38409922-BDEDBEEC-3C13-4288-AFB2-4CB6F8FF1B1EQ38836940-3BC4F587-AC09-4128-AB65-A55F3D0B6639Q38844824-3D3C9035-FDE9-42BE-9A7C-CBB928FA2407Q39082229-0068F7D5-119B-4387-AFFF-A8132F4A7320Q39461299-3EA59BF7-7377-4B74-9C97-18A683E1D55EQ39465599-C82F8D97-EA04-472A-ABCB-73BCDCE7DD3DQ40224114-14BEAF63-220E-496E-A460-75ED2720F939Q42600218-CFD44246-F7EC-4E78-A373-5E894F9F9391Q42632525-712BFE02-74ED-481B-BE30-472B7EB868A6Q44347700-D6294D89-6D23-4180-9D82-35E6ED1A52C3Q44395569-94F24809-4EF1-40AB-BAC1-769C064C3279Q45804471-566CB451-4393-4227-998B-4B2ED0179D32Q47210223-48A5A3B2-9F17-4596-887F-0502BCDD95DDQ47390598-51C87C0F-3857-476E-B9B8-BCDCFB15C29CQ47668300-BF5A3BC4-DBC0-417C-9A4D-EDEC11195E7FQ48252053-69A17DB3-485B-4BBA-9C03-03D30E249BE2Q48506361-D26FA9D8-C757-4067-8EEA-BC35F5F39728Q51811734-286312A3-91FB-4B6E-942A-38D79E4E29B8Q59221737-D3A71611-1B41-417B-9D4D-10C0ADEC26BEQ59221749-42DB8135-062C-4A51-A921-2C4048BA3EFDQ59221778-6AE7B551-435C-4CE3-9F58-D4AF0D526300Q59221786-7F130AF3-0D96-4CFB-B4E5-3AEF1747431BQ59221798-3EAC5BF4-DED2-4590-9575-423FA58D08E8Q60921961-7052EDF1-9563-43FC-BA11-4DBD719F1463Q61426652-2F19E57E-9F4B-49C9-8F24-9C6945268271Q88546178-C97B001D-6204-4C05-9274-A48EB888ED6DQ88644692-B10ED51C-D1BB-4ED8-A87C-7B761AA81926Q89455721-95CE0678-04B4-46ED-85D6-6B8ACE95047D
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Betty Chaar
@ast
Betty Chaar
@en
Betty Chaar
@es
Betty Chaar
@nl
Betty Chaar
@sl
type
label
Betty Chaar
@ast
Betty Chaar
@en
Betty Chaar
@es
Betty Chaar
@nl
Betty Chaar
@sl
prefLabel
Betty Chaar
@ast
Betty Chaar
@en
Betty Chaar
@es
Betty Chaar
@nl
Betty Chaar
@sl
P106
P21
P31
P496
0000-0001-8757-9403